A recent phase II clinical trial in Parkinsons disease, which assessed DFP in 372 newly diagnosed, untreated PD patients over 36 weeks, revealed that DFP not only failed to improve disease symptoms but was associated with a worsening of motor and non-motor symptoms compared to placebo (Negida et al., 2024), this did not translate into clinical benefit in PD patients
Avoid Harsh Products: We recommend our patients stop using harsh skincare products, including exfoliants or harsh cleansers, right after the treatment
Mitochondrial and inflammatory biomarkers may also provide clinical context
In patients who are already on dual antiplatelet therapy post-stent or who have bleeding disorders, additive antiplatelet effects could increase hemorrhagic risk
The Best Lip Balms By Samantha Schoech and Jennifer G
zcan G, Gndz AK, Mirzayev , et al